APR 29, 2021 4:35 PM CEST

Haematological malignancy samples molecular characterization - in a NGS way

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

Next Generation Sequencing (NGS) based molecular tests have been the one of the major focus for the expansion of molecular service provided by Haemato-oncology Diagnostic Service (HODS) in Royal Liverpool University Hospital. The move of NGS platform from Ion PGM to GeneStudio has enabled us to meet the requirement of molecular diagnosis for haematological malignancies. The further move to Genexus system is a way to improve turnaround time and capacity of the NGS tests. With Genexus platform we have been able to expand our NGS test repertoire even further to customised panels.  Customised panel based on Ion Ampliseq technologies provide the flexibility of NGS assay for both molecular diagnosis service and in depth molecular characterisation of haematological malignancy samples At an integrated part of the NGS platform evolution, the data analysis workflow has been optimized and validated to generate clinical relevant variant calling. The use of fusion transcript NGS screening for fusion transcript copy number change has also been explored.

Learning Objectives:

1. S5 evolution of service and benefits of NGS by Genexus

2. Set-up of Genexus in a Molecular Laboratory


Show Resources
You May Also Like
FEB 24, 2021 10:00 AM PST
C.E. CREDITS
FEB 24, 2021 10:00 AM PST
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
JAN 21, 2021 8:00 AM PST
JAN 21, 2021 8:00 AM PST
Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
MAR 30, 2021 8:00 AM PDT
MAR 30, 2021 8:00 AM PDT
DATE: March 30, 2021 TIME: 08:00am PST In this talk, we will discuss the value of moving towards modular and automated, closed-system technologies designed to enable scalable and cost-effect...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
APR 07, 2021 9:00 AM PDT
C.E. CREDITS
APR 07, 2021 9:00 AM PDT
One challenge pharmaceutical companies face, is moving promising biotherapeutic products into the clinic as fast as safely possible. Devoting the correct amount of time and resources to earl...
JUN 24, 2021 8:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
JUN 24, 2021 8:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...
Loading Comments...
Show Resources